One-liner#

Frequent urination and urgency require differentiation between infection, overactive bladder, BPH, and systemic causes like diabetes—with treatment tailored to the underlying etiology.

Quick nav#

• Red flags / send to ED
• Key history
• Focused exam
• Differential (quick pattern recognition)
• Workup
• Initial management
• Management by diagnosis
• Follow-up
• Patient instructions
• Smartphrase snippets

Red flags / send to ED#

• Urinary retention → unable to void despite strong urge; palpable bladder; needs catheterization
• New neurologic symptoms + urinary symptoms → cauda equina syndrome if saddle anesthesia, leg weakness, bowel incontinence
• Frequency + polydipsia + weight loss → new diabetes with possible DKA
• Gross hematuria with clots → may need urology evaluation urgently

Key history#

Characterize the symptoms:

• Frequency: how many times per day? Per night (nocturia)?
• Urgency: sudden compelling need to void; fear of leakage
• Incontinence: urge incontinence (leakage with urgency) vs stress (with cough/sneeze)
• Dysuria: suggests infection
• Duration: acute (days-weeks) vs chronic (months-years)
• Voiding diary: helpful for quantifying symptoms

Storage vs voiding symptoms (men):

• Storage (irritative): frequency, urgency, nocturia, urge incontinence
• Voiding (obstructive): hesitancy, weak stream, straining, incomplete emptying, post-void dribbling
• BPH typically causes both; pure storage symptoms suggest OAB

Associated symptoms:

• Dysuria, hematuria → UTI
• Polydipsia, weight loss → diabetes mellitus or insipidus
• Vaginal dryness, dyspareunia → atrophic vaginitis
• Constipation → can worsen OAB
• Neurologic symptoms → MS, Parkinson’s, spinal cord pathology

Fluid intake:

• Total daily intake (many patients drink excessively)
• Caffeine intake (bladder irritant)
• Alcohol intake (diuretic, irritant)
• Timing of fluid intake (evening intake causes nocturia)

Medications causing or worsening symptoms:

• Diuretics (obvious cause of frequency)
• Caffeine, alcohol
• Alpha-blockers (can cause incontinence)
• Cholinesterase inhibitors (increase bladder contractility)
• Lithium (diabetes insipidus)
• ACE inhibitors (cough → stress incontinence)
• Anticholinergics (retention → overflow)

Functional considerations:

• Mobility limitations affecting ability to reach bathroom
• Cognitive impairment
• Access to bathroom (workplace, travel)

Focused exam#

Vital signs:

• Generally normal unless systemic illness

Abdominal exam:

• Suprapubic tenderness → cystitis
• Palpable bladder → retention
• Abdominal mass

GU exam (men):

• Prostate: size, consistency, nodules (DRE)
• Urethral meatus: discharge, stenosis
• Phimosis

Pelvic exam (women):

• Atrophic changes: pale, dry mucosa; loss of rugae
• Pelvic organ prolapse: cystocele, uterine prolapse
• Urethral caruncle
• Pelvic mass

Neurologic exam (if neurogenic cause suspected):

• Perineal sensation (S2-S4)
• Anal tone
• Lower extremity strength and reflexes
• Gait

Bladder assessment:

• Post-void residual (PVR): bladder scan or catheterization
• PVR >200 mL suggests incomplete emptying

Differential (quick pattern recognition)#

Common/likely (outpatient)#

Can’t-miss / urgent#

Workup#

All patients:

• UA: rule out infection, hematuria, glucosuria
• Consider voiding diary (3 days): documents frequency, volume, fluid intake

Men with LUTS:

• PSA: if life expectancy >10 years and would consider treatment
• Post-void residual (PVR): bladder scan or catheterization
• BMP: if concern for obstruction affecting renal function

Women with OAB symptoms:

• UA to rule out UTI
• PVR if concern for retention
• Consider pelvic exam if atrophy or prolapse suspected

If diabetes suspected:

• Fingerstick glucose or HbA1c
• BMP

If hematuria present:

• Full hematuria workup (see hematuria page)

When to check PVR:

• Men with LUTS (especially voiding symptoms)
• Patients on anticholinergics (before starting and after)
• Neurologic conditions
• Diabetes with neuropathy
• Symptoms of incomplete emptying
• Prior to starting OAB medications

When NOT to order:

• Do NOT order cystoscopy for straightforward OAB without hematuria or other red flags
• Do NOT order urodynamics in primary care—this is a urology test
• Do NOT check PSA without discussing implications with patient first

Initial management#

UTI:

• Treat infection; reassess symptoms after treatment
• See dysuria page for antibiotic selection

Overactive bladder:

• Start with behavioral therapy (first-line)
• Add pharmacotherapy if behavioral measures insufficient

BPH:

• Alpha-blocker for moderate-severe symptoms
• 5-alpha reductase inhibitor if prostate >30g
• Combination therapy for large prostates with significant symptoms

Excessive fluid/caffeine:

• Reduce intake; target 6-8 glasses water daily
• Limit caffeine to 1-2 cups coffee equivalent
• Avoid fluids 2-3 hours before bed for nocturia

Atrophic vaginitis:

• Vaginal estrogen (see dysuria page for options)

Management by diagnosis#

Overactive Bladder (OAB)#

Education:

• Common condition; not dangerous but affects quality of life
• Behavioral changes are first-line and often very effective
• Medications help but have side effects, especially in elderly
• Improvement takes weeks; be patient

Behavioral therapy (first-line):

• Bladder training: scheduled voiding, gradually increasing intervals; goal 3-4 hours between voids
• Urge suppression: when urge hits, stop, squeeze pelvic floor, wait for urge to pass, then walk to bathroom
• Fluid management: moderate intake (6-8 cups/day); avoid caffeine, alcohol, artificial sweeteners
• Timed voiding: void by the clock, not by urge
• Pelvic floor exercises (Kegels): strengthen pelvic floor; 10 contractions, 3x daily

Pharmacotherapy (if behavioral therapy insufficient):

Anticholinergic warnings (especially elderly):

• Cognitive impairment (avoid in dementia)
• Constipation
• Dry mouth
• Urinary retention (check PVR)
• Falls risk
• Heat intolerance
• Beers criteria: avoid oxybutynin IR in elderly

If anticholinergics contraindicated or not tolerated:

• Use beta-3 agonist (mirabegron or vibegron)
• More expensive but no anticholinergic burden

Follow-up: 4-6 weeks to assess response. If no improvement, consider urology referral for further evaluation (urodynamics, botox, neuromodulation).

BPH (Benign Prostatic Hyperplasia)#

Education:

• Prostate enlargement is normal with aging
• Not cancer, but symptoms can significantly affect quality of life
• Medications can help; surgery is an option if medications fail
• Symptoms may worsen over time without treatment

When to treat:

• Bothersome symptoms affecting quality of life
• Use AUA Symptom Index (AUASI) to quantify: mild (0-7), moderate (8-19), severe (20-35)

Treatment:

Combination therapy:

• Alpha-blocker + 5-ARI for large prostates (>30-40g) with significant symptoms
• More effective than monotherapy for preventing progression

Alpha-blocker counseling:

• Orthostatic hypotension: rise slowly, especially at night
• Retrograde ejaculation: “dry orgasm”—not harmful but bothersome
• Intraoperative floppy iris syndrome: inform ophthalmologist before cataract surgery

5-ARI counseling:

• Takes 6 months for full effect
• Decreases PSA by ~50%—must double PSA value for cancer screening
• Sexual side effects: decreased libido, ED, decreased ejaculate volume
• Small increased risk of high-grade prostate cancer (controversial)

Urology referral:

• Refractory symptoms despite medical therapy
• Recurrent UTIs
• Bladder stones
• Renal insufficiency from obstruction
• Urinary retention
• Gross hematuria
• Elevated PVR (>200-300 mL) despite treatment

Follow-up: 4-6 weeks after starting alpha-blocker; 6 months for 5-ARI. Repeat AUASI, PVR.

Nocturia#

Education:

• Waking to urinate at night; very common, especially with age
• Multiple causes: fluid intake, BPH, OAB, sleep apnea, heart failure, diabetes
• Often multifactorial

Evaluation:

• Voiding diary essential: distinguish nocturnal polyuria (>33% of 24-hour output at night) from reduced bladder capacity
• Consider: sleep apnea (snoring, daytime sleepiness), HF (edema, orthopnea), diabetes

Management by cause:

• Nocturnal polyuria: fluid restriction after 6 PM; elevate legs in evening; treat HF/edema
• Reduced bladder capacity: treat underlying OAB or BPH
• Sleep apnea: sleep study; CPAP often improves nocturia
• Desmopressin: 25-50 mcg intranasal or 0.1-0.2 mg PO at bedtime; AVOID in elderly (hyponatremia risk), HF, CKD

Follow-up: 4-6 weeks; repeat voiding diary.

Interstitial Cystitis/Bladder Pain Syndrome#

Recognition:

• Chronic pelvic pain/pressure related to bladder
• Urgency and frequency (can be extreme—up to 60 voids/day)
• Pain often relieved by voiding
• Diagnosis of exclusion

PCP role:

• Recognize pattern and refer to urology
• Rule out UTI, malignancy
• Avoid repeated antibiotic courses for negative cultures

Initial management while awaiting urology:

• Dietary modification: avoid bladder irritants (caffeine, alcohol, acidic foods, artificial sweeteners)
• OTC phenazopyridine for flares
• Avoid anticholinergics (usually ineffective)

Referral: Urology for cystoscopy, hydrodistension, intravesical therapy.

Follow-up#

OAB:

• 4-6 weeks after starting behavioral or pharmacologic therapy
• Assess symptom improvement, side effects
• Check PVR if on anticholinergics

BPH:

• 4-6 weeks after starting alpha-blocker
• 6 months after starting 5-ARI
• Annual PSA (remember to double value if on 5-ARI)

Return precautions:

• Blood in urine
• Fever or pain with urination
• Unable to urinate at all
• Symptoms significantly worsening
• New incontinence

Patient instructions#

For overactive bladder:

• Try to gradually increase time between bathroom trips
• When you feel the urge, stop, squeeze your pelvic muscles, wait for the urge to pass, then walk calmly to the bathroom
• Cut back on caffeine and alcohol—they irritate the bladder
• Don’t drink too much or too little; 6-8 glasses of water daily is usually right
• Do pelvic floor exercises (Kegels) daily

For BPH:

• Take your medication as prescribed; it may take a few weeks to notice improvement
• Rise slowly from sitting or lying to avoid dizziness
• Avoid decongestants (Sudafed)—they can make it harder to urinate
• Limit fluids before bed to reduce nighttime trips
• Call if you cannot urinate at all—this is an emergency

Smartphrase snippets#

OAB, starting behavioral therapy: “Symptoms consistent with overactive bladder—urgency, frequency, nocturia without dysuria or hematuria. UA negative. Starting behavioral therapy: bladder training, urge suppression techniques, fluid/caffeine modification, pelvic floor exercises. Handout provided. Follow-up in 4-6 weeks; will consider pharmacotherapy if insufficient response.”

BPH, starting alpha-blocker: “LUTS consistent with BPH—AUASI score [X] (moderate/severe). DRE: [enlarged/benign]. PSA [X]. PVR [X] mL. Starting tamsulosin 0.4 mg daily. Counseled on orthostatic precautions and retrograde ejaculation. Follow-up in 4-6 weeks. Urology referral if inadequate response or complications.”

OAB, starting medication: “OAB with inadequate response to behavioral therapy. No contraindications to anticholinergics. Starting [medication] [dose]. Counseled on side effects including dry mouth, constipation, and cognitive effects. PVR checked: [X] mL. Follow-up in 4-6 weeks.”

Related pages#

• Benign Prostatic Hyperplasia (problem) — comprehensive BPH management including alpha-blockers, 5-ARIs, and surgical referral criteria
• Chronic Kidney Disease (problem) — CKD can cause nocturia and polyuria; medication adjustments needed